Kite, a Gilead Sciences company, will share four posters that add to the growing body of evidence to support the clinical use of its chimeric antigen receptor (CAR) T-cell therapy portfolio, at the ...

Marking World Cancer Day 2025, this week's Executive Q&A is with Diego Santoro, General Manager & Head of International ...

近日，由纪念斯隆-凯特琳癌症中心Sham Mailankody领衔的研究团队，在顶级医学期刊《新英格兰医学杂志》发表了一个罕见的病例报道 [3]。他们在一例接受CAR-T治疗后继发CD4阳性T细胞 淋巴瘤 ...